Dynamic and selective HERV RNA expression in neuroblastoma cells subjected to variation in oxygen tension and demethylation

APMIS

Volumn 124, Issue 1-2, 2016, Pages 140-149

  Hu, Lijuan ^a   Uzhameckis, Dmitrijs ^a   Hedborg, Fredrik ^a   Blomberg, Jonas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Co option; Demethylation; Human endogenous retroviral sequences; Hypoxia; Neuroblastoma; RNA expression

Indexed keywords

HISTONE; HUMAN ENDOGENOUS RETROVIRUS RNA; UNCLASSIFIED DRUG; VIRUS RNA; AZACITIDINE; ENZYME INHIBITOR; OXYGEN;

A549 CELL LINE; ARTICLE; CONTROLLED STUDY; COS 1 CELL LINE; DEMETHYLATION; ENDOGENOUS RETROVIRUS; GENETIC VARIABILITY; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HYPOXIA; NEUROBLASTOMA; NEUROBLASTOMA CELL LINE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; UPREGULATION; VIRUS EXPRESSION; CELL HYPOXIA; CELL PROLIFERATION; CLASSIFICATION; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION; TUMOR CELL LINE; VIROLOGY; VIRUS ACTIVATION;

AZACITIDINE; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOGENOUS RETROVIRUSES; ENZYME INHIBITORS; HUMANS; NEUROBLASTOMA; OXYGEN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA, VIRAL; UP-REGULATION; VIRUS ACTIVATION;

EID: 84969389439     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12494     Document Type: Article

References (69)

1. La Mantia G, Maglione D, Pengue G, Di Cristofano A, Simeone A, Lanfrancone L, et al. Identification and characterization of novel human endogenous retroviral sequences prefentially expressed in undifferentiated embryonal carcinoma cells. Nucleic Acids Res 1991;19:1513-20.
2. Blomberg J, Uzhameckis D, Jern P. Evolutionary aspects of human endogenous retroviral sequences (HERVs) and disease. In: Sverdlov E, editor. Retroviruses in Primate Evolution. Georgetown: Eurekah/LandesBioscience; 2005; 204-38.
3. Ling J, Pi W, Bollag R, Zeng S, Keskintepe M, Saliman H, et al. The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol 2002;76:2410-23.
4. Schramke V, Allshire R. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 2003;301:1069-74.
5. Medstrand P, Landry JR, Mager DL. Long terminal repeats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans. J Biol Chem 2001;276:1896-903.
6. Schon U, Seifarth W, Baust C, Hohenadl C, Erfle V, Leib-Mosch C. Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology 2001;279:280-91.
7. Domansky AN, Kopantzev EP, Snezhkov EV, Lebedev YB, Leib-Mosch C, Sverdlov ED. Solitary HERV-K LTRs possess bi-directional promoter activity and contain a negative regulatory element in the U5 region. FEBS Lett 2000;472:191-5.
8. Cheng YH, Richardson BD, Hubert MA, Handwerger S. Isolation and characterization of the human syncytin gene promoter. Biol Reprod 2004;70:694-701.
9. Lee WJ, Kwun HJ, Jang KL. Analysis of transcriptional regulatory sequences in the human endogenous retrovirus W long terminal repeat. J Gen Virol 2003;84:2229-35.
10. Andersson AC, Venables PJ, Tonjes RR, Scherer J, Eriksson L, Larsson E. Developmental expression of HERV-R (ERV3) and HERV-K in human tissue. Virology 2002;297:220-5.
11. Blaise S, de Parseval N, Benit L, Heidmann T. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci U S A 2003;100:13013-8.
12. Blaise S, de Parseval N, Heidmann T. Functional characterization of two newly identified human endogenous retrovirus coding envelope genes. Retrovirology 2005;2:19.
13. Kamme F. Changes in Gene Expression during Delayed Neuronal Death after Cerebral Ischemia in the Rat. Lund: Lund University, 1998.
14. Muir A, Lever A, Moffett A. Expression and functions of human endogenous retroviruses in the placenta: an update. Placenta 2004;25(Suppl A):S16-25.
15. Rasheed S. Retroviruses and oncogenes in rats. In: Gallo R, editor. Retroviruses and Human Pathology. Clifton, NJ: Humana Press, 1986: 153-75.
16. Venables PJ, Brookes SM, Griffiths D, Weiss RA, Boyd MT. Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 1995;211:589-92.
17. Gordan JD, Simon MC. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 2007;17:71-7.
18. Laconi E. The evolving concept of tumor microenvironments. BioEssays 2007;29:738-44.
19. Altshuler G. A conceptual approach to placental pathology and pregnancy outcome. Semin Diagn Pathol 1993;10:204-21.
20. Carter AM. Factors affecting gas transfer across the placenta and the oxygen supply to the fetus. J Dev Physiol 1989;12:305-22.
21. Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol 2003;110(Suppl 1):S99-107.
22. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006;12:747-55.
23. Walker DW, Lee B, Nitsos I. Effect of hypoxia on respiratory activity in the foetus. Clin Exp Pharmacol Physiol 2000;27:110-3.
24. Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004;7:1088-95.
25. Anderson GR, Stoler DL. Anoxia, wound healing, VL30 elements, and the molecular basis of malignant conversion. BioEssays 1993;15:265-72.
26. Firulli BA, Anderson GR, Stoler DL, Estes SD. Anoxia-inducible rat VL30 elements and their relationship to ras-containing sarcoma viruses. J Virol 1993;67:6857-62.
27. Hsieh LL, Peraino C, Weinstein IB. Expression of endogenous retrovirus-like sequences and cellular oncogenes during phenobarbital treatment and regeneration in rat liver. Cancer Res 1988;48:265-9.
28. Rodland KD, Jue SF, Magun BE. Regulation of VL30 gene expression by activators of protein kinase C. J Biol Chem 1986;261:5029-33.
29. Weber HW, Geddes A, Stellwagen RH. Induction of intracisternal type A particles by 5-bromo-2′-deoxyuridine in rat hepatoma cells. J Natl Cancer Inst 1978;60:919-23.
30. Ameri K, Burke B, Lewis CE, Harris AL. Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1. Br J Cancer 2002;87:1173-81.
31. Anderson GR, Stoler DL, Scarcello LA. Retrotransposon-like VL30 elements are efficiently induced in anoxic rat fibroblasts. J Mol Biol 1989;205:765-9.
32. Estes SD, Stoler DL, Anderson GR. Anoxic induction of a sarcoma virus-related VL30 retrotransposon is mediated by a cis-acting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor. J Virol 1995;69:6335-41.
33. Lee X, Keith JC Jr, Stumm N, Moutsatsos I, McCoy JM, Crum CP, et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001;22:808-12.
34. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A 1997;94:7583-8.
35. Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci U S A 2001;98:4634-9.
36. Nakamura A, Okazaki Y, Sugimoto J, Oda T, Jinno Y. Human endogenous retroviruses with transcriptional potential in the brain. J Hum Genet 2003;48:575-81.
37. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev 2000;31:193-9.
38. Forsman A, Yun Z, Hu L, Uzhameckis D, Jern P, Blomberg J. Development of broadly targeted human endogenous gammaretroviral pol-based real time PCRs. Quantitation of RNA expression in human tissues. J Virol Methods 2005;129:16-30.
39. Uzhameckis D, Chapenko S, Logina I, Murovska M, Blomberg J. No definite evidence for human endogenous retroviral HERV-W and HERV-H RNAs in plasma of Latvian patients suffering from multiple sclerosis and other neurological diseases. Submitted to Proc Latv Acad Sci B Nat Exact Appl Sci; 2005, in press.
40. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
41. Vargiu L, Rodriguez-Tomé P, Sperber GO, Cadeddu M, Grandi N, Blikstad V, et al. Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology 2015; In press. Accepted for publication.
42. Dietel M, Arps H, Gerding D, Trapp M, Niendorf A. Establishment of primary cell cultures: experiences with 155 cell strains. Klin Wochenschr 1987;65:507-12.
43. Lindskog U, Lundgren B, Billig D, Lindner E. Alternatives for harvesting cells grown on microcarriers: effects on subsequent attachment and growth. Dev Biol Stand 1987;66:307-13.
44. Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003;44:183-9.
45. Riggs AD. DNA methylation and late replication probably aid cell memory, and type I DNA reeling could aid chromosome folding and enhancer function. Philos Trans R Soc Lond B Biol Sci 1990;326:285-97.
46. Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol 2000;183:145-54.
47. Momparler RL, Eliopoulos N, Ayoub J. Evaluation of an inhibitor of DNA methylation, 5-aza-2′-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy. Adv Exp Med Biol 2000;465:433-46.
48. Katz RA, Jack-Scott E, Narezkina A, Palagin I, Boimel P, Kulkosky J, et al. High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms. J Virol 2007;81:2592-604.
49. Bednarik DP. DNA methylation and retrovirus expression. Exs 1993;64:300-29.
50. Ellis J, Yao S. Retrovirus silencing and vector design: relevance to normal and cancer stem cells? Curr Gene Ther 2005;5:367-73.
51. Hedges DJ, Batzer MA. From the margins of the genome: mobile elements shape primate evolution. BioEssays 2005;27:785-94.
52. Pannell D, Ellis J. Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol 2001;11:205-17.
53. Quivy V, Calomme C, Dekoninck A, Demonte D, Bex F, Lamsoul I, et al. Gene activation and gene silencing: a subtle equilibrium. Cloning Stem Cells 2004;6:140-9.
54. Reiss D, Mager DL. Stochastic epigenetic silencing of retrotransposons: does stability come with age? Gene 2007;390:130-5.
55. Swindle CS, Klug CA. Mechanisms that regulate silencing of gene expression from retroviral vectors. J Hematother Stem Cell Res 2002;11:449-56.
56. Svoboda J, Hejnar J, Geryk J, Elleder D, Vernerova Z. Retroviruses in foreign species and the problem of provirus silencing. Gene 2000;261:181-8.
57. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997;13:335-40.
58. Sperber GO, Airola T, Jern P, Blomberg J. Automated recognition of retroviral sequences in genomic data RetroTector(C). Nucleic Acids Res 2007;35:4964-76.
59. Bonnaud B, Bouton O, Oriol G, Cheynet V, Duret L, Mallet F. Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation. Mol Biol Evol 2004;21:1895-901.
60. Cheynet V, Ruggieri A, Oriol G, Blond JL, Boson B, Vachot L, et al. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J Virol 2005;79:5585-93.
61. Frendo JL, Olivier D, Cheynet V, Blond JL, Bouton O, Vidaud M, et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 2003;23:3566-74.
62. Malassine A, Handschuh K, Tsatsaris V, Gerbaud P, Cheynet V, Oriol G, et al. Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta 2005;26:556-62.
63. Mallet F, Bouton O, Prudhomme S, Cheynet V, Oriol G, Bonnaud B, et al. The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology. Proc Natl Acad Sci U S A 2004;101:1731-6.
64. Prudhomme S, Oriol G, Mallet F. A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol 2004;78:12157-68.
65. Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2003;60:1376-93.
66. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611.
67. Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 2004;3:29-35.
68. Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, Dayan F, et al. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004;68:971-80.
69. Seta KA, Millhorn DE. Functional genomics approach to hypoxia signaling. J Appl Physiol 2004;96:765-73.